SiteOne Therapeutics Raises $15M

San Francisco- and Bozeman, Montana-based SiteOne Therapeutics said on Friday that it has raised $15M in a Series B investment round. The funding was led by Amgen, and also included Next Frontier and other investors. SiteOne is developing no-opioid analgesics, aimed at treating chronic pain without causing addition. The company had its headquarters in Montana, but has its research operations in San Francisco. More information »